Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

12

Revenue 2014

Amgen

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Amgen's 2013 sales performance.

CETP inhibitor class finally dies as Merck abandons anacetrapib

CETP inhibitor class finally dies as Merck abandons anacetrapib

In the interim almost all of those brands have succumbed to generic competition, and new innovative drugs - such as the PCSK9 inhibitors from Amgen and Sanofi/Regeneron - have found it hard

Finalists 2017

by Amgen. with support from Atlantis Healthcare UK. The Bayer iMCM Lighthouse Project. ... by Amgen. with support from Atlantis Healthcare UK. Delivering Innovation in a Rare Disease Launch.

US court lifts ban on sales of Sanofi's Praluent

US court lifts ban on sales of Sanofi's Praluent US court lifts ban on sales of Sanofi's Praluent. The duo can continue to compete against Amgen's rival PCSK9 Repatha. ... Praluent was approved in the US first, but Amgen filed a patent infringement suit after securing approval for its own PCSK9 drug

US court nixes ban on sales of Sanofi, Regeneron's Praluent

US court nixes ban on sales of Sanofi, Regeneron's Praluent US court nixes ban on sales of Sanofi, Regeneron's Praluent. The duo can continue to compete against Amgen's Repatha. ... Praluent was approved in the US first, but Amgen filed a patent infringement suit after securing approval for its own PCSK9 drug

Amgen pledges $1.5bn for CytomX preclinical cancer drugs

Amgen pledges $1.5bn for CytomX preclinical cancer drugs Amgen pledges $1.5bn for CytomX preclinical cancer drugs. Stellar valuations for immuno-oncology candidates continue. ... In an unusual development, CytomX also gets a stake in an unnamed T-cell engaging bispecific developed at Amgen.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health offers a unique breadth and depth of experience, across everything from early stage product commercialisation, strategy and research,...

Latest intelligence

Digital
Tools for the digital world
The next step for the pharma industry...
How Can We Make Payer Communications Really Sing?
With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...

Infographics